Cancer stem cells-A therapeutic target?

Current Opinion in Molecular Therapeutics

Volumn 12, Issue 6, 2010, Pages 662-673

  Maitland, Norman J ^a   Collins, Anne T ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Cancer stem cells; CSCs; resistance; self renewal; target; therapeutic development

Indexed keywords

BMI1 PROTEIN; DOXORUBICIN; GAMMA SECRETASE INHIBITOR; IRINOTECAN; METFORMIN; NOTCH RECEPTOR; SALINOMYCIN; SONIC HEDGEHOG PROTEIN; TELOMERASE; WNT PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BLADDER CANCER; BREAST CANCER; BREAST TUMOR; CANCER STEM CELL; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL REGENERATION; COLON CANCER; DRUG DEVELOPMENT; ENDOMETRIUM CANCER; GLIOBLASTOMA; HEAD AND NECK CANCER; HUMAN; KIDNEY CANCER; LIVER CANCER; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; MEDULLOBLASTOMA; MELANOMA; MULTIPLE MYELOMA; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TELOMERE; VIROTHERAPY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASTIC STEM CELLS; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 79952968109     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Julius Cohnheim 1839-1884) experimental pathologist. JAMA (1968) 206(7) 1561-1562.
2. Furth J, Kahn MC: The transmission of leukaemia of mice with a single cell. Am J Cancer (1937) 31:276-282.
3. Wodinsky I, Swiniarski J, Kensler CJ: Spleen colony studies of leukemia L1210. 3. Differential sensitivities of normal hematopoietic and resistant L1210 colony-forming cells to 6-mercaptopurine (NSC-755). Cancer Chemother Rep (1968) 52(2):251-255.
4. Hamburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Science (1977) 197(4302):461-463.
5. MacKillop WJ, Ciampi A, Till JE, Buick RN: A stem cell model of human tumor growth: Implications for tumor cell clonogenic assays. J Natl Cancer Inst (1983) 70(1):9-16. (Pubitemid 13138325) (Pubitemid 13138325)
6. Greaves MF, Hariri G, Newman RA, Sutherland DR, Ritter MA, Ritz J: Selective expression of the common acute lymphoblastic leukemia (GP 100) antigen on immature lymphoid cells and their malignant counterparts. Blood (1983) 61(4):628-639. (Pubitemid 13115360) (Pubitemid 13115360)
7. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature (1994) 367(6464):645-648. (Pubitemid 24067706) (Pubitemid 24067706)
8. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 3(7):730-737. (Pubitemid 27298715) (Pubitemid 27298715)
9. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identifcation of tumorigenic prostate cancer stem cells. Cancer Res (2005) 65(23):10946-10951. (Pubitemid 41713363) (Pubitemid 41713363)
10. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A et al: CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors. J Clin Invest (2008) 118(6):2111-2120. (Pubitemid 351872330) (Pubitemid 351872330)
11. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK: Ovarian cancer side population defnes cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness. Proc Natl Acad Sci USA (2006) 103(30):11154-11159. (Pubitemid 44156488) (Pubitemid 44156488)
12. Salcido CD, Larochelle A, Taylor BJ, Dunbar CE, Varticovski L: Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer. Br J Cancer (2010) 102(11):1636-1644.
13. Lichtenauer UD, Shapiro I, Geiger K, Quinkler M, Fassnacht M, Nitschke R, Rückauer KD, Beuschlein F: Side population does not defne stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI H295R. Endocrinology (2008) 149(3): 1314-1322. (Pubitemid 351397918) (Pubitemid 351397918)
14. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM: Cancer stem cells-Perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res (2006) 66(19):9339-9344. (Pubitemid 44623625) (Pubitemid 44623625)
15. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ: Effcient tumor formation by single human melanoma cells. Nature (2008) 456(7222):593-598.
16. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, Ly DP, Butler PD, Yang GP, Joshua B, Kaplan MJ, Longaker MT et al: Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature (2010) 466 (7302):133-137.
17. Boman BM, Wicha MS: Cancer stem cells: A step towards the cure. J Clin Oncol (2008) 26(17):2795-2799.
18. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S: Induction of pluripotent stem cells from adult human fbroblasts by defned factors. Cell (2007) 131(5):861-872. (Pubitemid 350138099) (Pubitemid 350138099)
19. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II et al: Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 318(5858):1917-1920.
20. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H: Crypt stem cells as the cells-of-origin of intestinal cancer. Nature (2009) 457(7229):608-611.
21. Shoemaker RH: The NCI60 human tumour cell line anticancer drug screen. Nat Rev (2006) 6(10):813-823. (Pubitemid 44450469) (Pubitemid 44450469)
22. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK et al: Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell (2006) 9(5):391-403. (Pubitemid 43668737) (Pubitemid 43668737)
23. Amaravadi RK, Thompson CB: The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res (2007) 13(24):7271-7279.
24. Harmes DC, DiRenzo J: Cellular quiescence in mammary stem cells and breast tumor stem cells: Got testable hypotheses? J Mammary Gland Biol Neoplasia (2009) 14(1):19-27.
25. Dean M: ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia (2009) 14(1):3-9.
26. Keith WN, Thomson CM, Howcroft J, Maitland NJ, Shay JW: Seeding drug discovery: Integrating telomerase cancer biology and cellular senescence to uncover new therapeutic opportunities in targeting cancer stem cells. Drug Discov Today (2007) 12(15-16):611-621. (Pubitemid 47243706) (Pubitemid 47243706)
27. Zimmermann S, Voss M, Kaiser S, Kapp U, Waller CF, Martens UM: Lack of telomerase activity in human mesenchymal stem cells. Leukemia (2003) 17(6):1146-1149. (Pubitemid 36722246) (Pubitemid 36722246)
28. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature (1990) 346(6287):866-868.
29. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol (1995) 155(8):3711-3715.
30. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res (2005) 65(13): 5506-5511. (Pubitemid 40911148) (Pubitemid 40911148)
31. Shay JW, Keith WN: Targeting telomerase for cancer therapeutics. Br J Cancer (2008) 98(4):677-683. (Pubitemid 351272604) (Pubitemid 351272604)
32. Brower V: Telomerase-based therapies emerging slowly. J Natl Cancer Inst (2010) 102(8):520-521.
33. Feinberg AP, Ohlsson R, Henikoff S: The epigenetic progenitor origin of human cancer. Nat Rev Genet (2006) 7(1):21-33. (Pubitemid 41828945) (Pubitemid 41828945)
34. Guzman ML, Rossi RM, Karnischky L, Li X, Peterson DR, Howard DS, Jordan CT: The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood (2005) 105(11):4163-4169. (Pubitemid 40720758) (Pubitemid 40720758)
35. Birnie R, Bryce SD, Roome C, Dussupt V, Droop A, Lang SH, Berry PA, Hyde CF, Lewis JL, Stower MJ, Maitland NJ et al: Gene expression profling of human prostate cancer stem cells reveals a pro-infammatory phenotype and the importance of extracellular matrix interactions. Genome Biol (2008) 9(5):R83.
36. Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K: Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res (2009) 69(19):7507-7511.
37. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF: The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med (2007) 356(3):217-226. (Pubitemid 46143225) (Pubitemid 46143225)
38. Hill R, Wu H: PTEN, stem cells, and cancer stem cells. J Biol Chem (2009) 284(18):11755-11759.
39. Yilmaz OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, Morrison SJ: PTEN dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature (2006) 441(7092):475-482. (Pubitemid 44050144) (Pubitemid 44050144)
40. Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW, Holland EC: PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell (2009) 4(3):226-235.
41. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, Clarke MF: Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature (2003) 423(6937):302-305. (Pubitemid 40852701) (Pubitemid 40852701)
42. Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G: Bmi1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci (2009) 29(28):8884-8896.
43. Suvà ML, Riggi N, Janiszewska M, Radovanovic I, Provero P, Stehle JC, Baumer K, Le Bitoux MA, Marino D, Cironi L, Marquez VE et al: EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res (2009) 69(24):9211-9218.
44. Farnie G, Clarke RB, Spence K, Pinnock N, Brennan K, Anderson NG, Bundred NJ: Novel cell culture technique for primary ductal carcinoma in situ: Role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst (2007) 99(8):616-627. (Pubitemid 47073543) (Pubitemid 47073543)
45. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G et al: Notch pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells (2010) 28(1):5-16.
46. Niemann C, Unden AB, Lyle S, Zouboulis ChC, Toftgård R, Watt FM: Indian hedgehog and β-catenin signaling: Role in the sebaceous lineage of normal and neoplastic mammalian epidermis. Proc Natl Acad Sci USA (2003) 100(Suppl 1): 11873-11880. (Pubitemid 37205898) (Pubitemid 37205898)
47. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM, Beachy PA: Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature (2004) 431(7009):707-712. (Pubitemid 39382619) (Pubitemid 39382619)
48. Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D, Nannini-Pepe M et al: A paracrine requirement for hedgehog signalling in cancer. Nature (2008) 455(7211):406-410.
49. Tremblay MR, Nevalainen M, Nair SJ, Porter JR, Castro AC, Behnke ML, Yu LC, Hagel M, White K, Faia K, Grenier L et al: Semisynthetic cyclopamine analogues as potent and orally bioavailable Hedgehog pathway antagonists. J Med Chem (2008) 51(21):6646-6649.
50. Go MJ, Takenaka C, Ohgushi H: Forced expression of SOX2 or Nanog in human bone marrow derived mesenchymal stem cells maintains their expansion and differentiation capabilities. Exp Cell Res (2008) 314(5):1147-1154.
51. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT: CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci (2004) 117(Pt 16):3539-3545. (Pubitemid 39206394) (Pubitemid 39206394)
52. Frame FM, Hager S, Pellacani D, Stower MJ, Walker HF, Burns JE, Collins AT, Maitland NJ: Development and limitations of lentivirus vectors as tools for tracking differentiation in prostate epithelial cells. Exp Cell Res (2010) 316(19):3161-3171.
53. Short JJ, Curiel DT: Oncolytic adenoviruses targeted to cancer stem cells. Mol Cancer Ther (2009) 8(8):2096-2102.
54. Maitland NJ, Collins AT: Prostate cancer stem cells: A new target for therapy. J Clin Oncol (2008) 26(17):2862-2870.
55. Hoey T, Yen WC, Axelrod F, Basi J, Donigian L, Dylla S, Fitch-Bruhns M, Lazetic S, Park IK, Sato A, Satyal S et al: DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell (2009) 5(2):168-177.
56. Yan M, Callahan CA, Beyer JC, Allamneni KP, Zhang G, Ridgway JB, Niessen K, Plowman GD: Chronic DLL4 blockade induces vascular neoplasms. Nature (2010) 463(7282):E6-E7.
57. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES: Identifcation of selective inhibitors of cancer stem cells by high-throughput screening. Cell (2009) 138(4): 645-659.
58. Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, Chen L, Ewing CM, Eisenberger MA, Carducci MA, Nelson WG et al: Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med (2009) 15(5):559-565.
59. Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB: Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol (2007) 3(5):268-273. (Pubitemid 46625832) (Pubitemid 46625832)
60. Harrison NJ, Baker D, Andrews PW: Culture adaptation of embryonic stem cells echoes germ cell malignancy. Int J Androl (2007) 30(4):275-281. (Pubitemid 47254405)
61. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B et al: Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature (2009) 458(7239):780-783.
62. Huang J, Witte ON: A seminal fnding for prostate cancer? N Engl J Med (2010) 362(2):175-176.
63. Noordzij MA, van Steenbrugge GJ, van der Kwast TH, Schröder FH: Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate. Urol Res (1995) 22(6):333-341.
64. Hematopoietic cell lineage-Homo sapiens. KEGG Database, Kyoto, Japan (2009). www.genome.jp/kegg/pathway/hsa/hsa04640.html
65. Chan KS, Espinosa I, Chao M, Wong D, Ailles L, Diehn M, Gill H, Presti J Jr, Chang HY, van de Rijn M, Shortliffe L et al: Identifcation, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci USA (2009) 106(33):14016-14021.
66. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identifcation of tumorigenic breast cancer cells. Proc Natl Acad Sci USA (2003) 100(7):3983-3988. (Pubitemid 36418143) (Pubitemid 36418143)
67. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A et al: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell (2007) 1(5):555-567. (Pubitemid 350056407) (Pubitemid 350056407)
68. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA et al: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA (2007) 104(24):10158-10163. (Pubitemid 47175279) (Pubitemid 47175279)
69. O'Brien CA, Pollett A, Gallinger S, Dick JE: A human colon cancer cell capable of initiating tumor growth in immunodefcient mice. Nature (2007) 445(7123):106-110. (Pubitemid 46067310) (Pubitemid 46067310)
70. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R: Identifcation and expansion of human colon-cancer-initiating cells. Nature (2007) 445(7123):111-115. (Pubitemid 46067311) (Pubitemid 46067311)
71. Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, Ngan L, Pickell K, Aguilar J, Lazetic S, Smith-Berdan S, Clarke MF et al: Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One (2008) 3(6):e2428.
72. Hubbard SA, Friel AM, Kumar B, Zhang L, Rueda BR, Gargett CE: Evidence for cancer stem cells in human endometrial carcinoma. Cancer Res (2009) 69(21):8241-8248.
73. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identifcation of a cancer stem cell in human brain tumors. Cancer Res (2003) 63(18):5821-5828. (Pubitemid 37187480) (Pubitemid 37187480)
74. Bussolati B, Bruno S, Grange C, Ferrando U, Camussi G: Identifcation of a tumor-initiating stem cell population in human renal carcinomas. FASEB J (2008) 22(10):3696-3705.
75. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PW, Lam CT, Poon RT, Fan ST: Signifcance of CD90+ cancer stem cells in human liver cancer. Cancer Cell (2008) 13(2):153-166. (Pubitemid 351163165) (Pubitemid 351163165)
76. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R: Identifcation and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ (2008) 15(3):504-514. (Pubitemid 351267301) (Pubitemid 351267301)
77. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identifcation of human brain tumour initiating cells. Nature (2004) 432(7015): 396-401. (Pubitemid 39551674) (Pubitemid 39551674)
78. Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, Fuhlbrigge RC et al: Identifcation of cells initiating human melanomas. Nature (2008) 451(7176):345-349.
79. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP: Identifcation and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res (2008) 68(11):4311-4320.
80. Pan Y, Huang X: Epithelial ovarian cancer stem cells-A review. Int J Clin Exp Med (2008) 1(3):260-266.
81. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE: Identifcation of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA (2007) 104(3):973-978. (Pubitemid 46154721) (Pubitemid 46154721)
82. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo JF: Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res (2008) 14(13): 4085-4095.
83. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM: Identifcation of pancreatic cancer stem cells. Cancer Res (2007) 67(3):1030-1037.
84. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ, Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell (2007) 1(3):313-323. (Pubitemid 47355323) (Pubitemid 47355323)
85. Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, Nakamura R, Tanaka T, Tomiyama H, Saito N, Fukata M et al: Chemotherapy- resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol (2007) 25(11):1315-1321. (Pubitemid 350076512) (Pubitemid 350076512)
86. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, Smith BD, Civin CI, Jones RJ: Characterization of clonogenic multiple myeloma cells. Blood (2004) 103(6):2332-2336. (Pubitemid 38326254) (Pubitemid 38326254)
87. Cox CV, Evely RS, Oakhill A, Pamphilon DH, Goulden NJ, Blair A: Characterization of acute lymphoblastic leukemia progenitor cells. Blood (2004) 104(9):2919-2925. (Pubitemid 39434980) (Pubitemid 39434980)
88. Castor A, Nilsson L, Astrand-Grundström I, Buitenhuis M, Ramirez C, Anderson K, Strömbeck B, Garwicz S, Békássy AN, Schmiegelow K, Lausen B et al: Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med (2005) 11(6):630-637. (Pubitemid 40868303) (Pubitemid 40868303)
89. Cox CV, Martin HM, Kearns PR, Virgo P, Evely RS, Blair A: Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia. Blood (2007) 109(2): 674-682. (Pubitemid 46105969) (Pubitemid 46105969)
90. Park CY, Tseng D, Weissman IL: Cancer stem cell-directed therapies: Recent data from the laboratory and clinic. Mol Ther (2009) 17(2):219-230.